UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

29 Apr 2010

UCB: Delivering for patients through innovation

Read More
29 Apr 2010

Interim Report - Cimzia®, Vimpat® and Neupro® build momentum

Read More
23 Apr 2010

UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro® (Rotigotine)

Read More
14 Apr 2010

New data presented at the American Academy of Neurology meeting showed that Neupro® (rotigotine transdermal system) improved both motor and non-motor symptoms of Parkinson's disease

Read More
13 Apr 2010

New data showed sustained 5-year benefit of Neupro® (rotigotine transdermal system) on symptoms of Restless Legs Syndrome

Read More
29 Mar 2010

New members of UCB's Board of Directors

Read More

Stay up-to-date on the latest news and information from UCB